%D9%84%D9%86%D8%B2%D9%88%D9%84%D9%8A%D8%AF%D9%84%DB%8C%D9%86%D8%B2%D9%88%D9%84%DB%8C%D8%AFCategory:LinezolidLinesolidLinezolidLinezolidLinezolid%D9%84%DB%8C%D9%86%D8%B2%D9%88%D9%84%DB%8C%D8%AFLinetsolidiLin%C3%A9zolideLinezolid%D7%9C%D7%99%D7%A0%D7%96%D7%95%D7%9C%D7%99%D7%93LinezolidLinezolid%E3%83%AA%E3%83%8D%E3%82%BE%E3%83%AA%E3%83%89%EB%A6%AC%EB%84%A4%EC%A1%B8%EB%A6%AC%EB%93%9C%E0%B4%B2%E0%B5%88%E0%B5%BB%E0%B4%B8%E0%B5%8B%E0%B4%B3%E0%B4%BF%E0%B4%A1%E0%B5%8D%E0%AC%B2%E0%AC%BF%E0%AC%A8%E0%AD%87%E0%AC%9C%E0%AD%8B%E0%AC%B2%E0%AC%BF%E0%AC%A1LinezolidLinezolidaLinezolid%D0%9B%D0%B8%D0%BD%D0%B5%D0%B7%D0%BE%D0%BB%D0%B8%D0%B4LinezolidLinezolidLinezolidLinezolidLinezolid%E0%B9%84%E0%B8%A5%E0%B8%99%E0%B8%B4%E0%B9%82%E0%B8%8B%E0%B8%A5%E0%B8%B4%E0%B8%94Linezolid%D0%9B%D1%96%D0%BD%D0%B5%D0%B7%D0%BE%D0%BB%D1%96%D0%B4LinezolidQ411377%E5%88%A9%E5%A5%88%E5%94%91%E8%83%BA
about
P3781
NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TBLinezolid Instead of Ethambutol in Treatment of Drug-susceptible TuberculosisSafety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) InfectionsOral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive InfectionsStudy the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious DiseasesContezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionStudy the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream InfectionsSkin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)Pharmacokinetic Study of Linezolid for TB MeningitisPost Marketing Surveillance Study on LinezolidEvaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or VancomycinClinical Trials to Reduce the Risk of Antimicrobial ResistanceDrug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis PatientsTR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCost Study of Linezolid Versus Vancomycin Among Previously Hospitalized PatientsEfficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsVitamin B6 on Relieving Linezolid-associated CytopeniasComparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary TB, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNix)Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMPlasma and Lung Tissue Concentrations of Linezolid in Septic Shock PatientsRetrospective Real-word Study of Linezolid for the Treatment of Tuberculous MeningitisEvaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (2011-07-31)Ceftobiprole in Hospital Acquired Pneumonia (2005-04-30)Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
P4844
Correlation between serum linezolid concentration and the development of thrombocytopenia.Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data.A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.Management of gram-positive bacterial infections in patients with cancer.Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot studyTransferable multidrug resistance plasmid carrying cfr associated with tet(L), ant(4')-Ia, and dfrK genes from a clinical methicillin-resistant Staphylococcus aureus ST125 strain.Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model.Linezolid in Combination With Azoles Induced Synergistic Effects Against and Protected Against Experimental CandidiasisMolecular Analysis of Linezolid-Resistant Clinical Isolates ofLinezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled StudyOsteomyelitis due to methicillin-resistant successfully treated by an oral combination of minocycline and trimethoprim-sulfamethoxazolePhysicochemical Compatibility and Stability of Linezolid with Parenteral NutritionComparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremiaLinezolid-resistant in leukemia patients: Rare cases with review of literatureSerotonin Syndrome Induced by Combined Use of Sertraline and LinezolidSuccessful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
P921
Q61907366-2D0B724F-7B38-46B7-858E-2F01DEB22344Q61969776-DACF48DD-AC9D-4FAA-8FEB-25AF9C2D4A0CQ61975607-440EB8C9-06F4-460E-9923-8500C52C9F8DQ61980362-B9106646-09D7-401F-9A5B-37E20764D9E9Q61981086-0743C8DA-D71F-4D0E-B89C-FCEC0E9D8381Q62025985-524E75E9-A04C-4AFB-B2E7-A1B36E38A997Q62034326-C22618E0-5478-46D5-89D4-4B94FCD85C94Q62040856-0C151312-D1F8-4B55-8D63-2D507B90CA52Q62105488-83CB83B0-0BA8-42E5-B532-60451F8CED2BQ62110401-C9275AA1-B702-4DC8-89E8-0F53534CC474Q62110765-D335DA09-E9D0-4AB2-9352-36FEDED02435Q62813561-0E05C6D6-A1BA-4671-97C1-5094B13C1651Q63315802-AC0DF463-7D79-4577-9415-8E7D8980B4F5Q63316392-7D42FC14-51A5-4118-A941-E4B7262B4B5CQ63316977-C6B5C827-AF66-42C1-ACED-1199FF0A8F76Q63320101-FA1EDC84-6D9B-4AE4-8473-4D01A199C52AQ63322080-CB416D07-8C4B-4123-AC8B-E84879A7DC7FQ63334529-20C31C7D-1094-45C2-A1E4-C8E0A87AC0BBQ63335211-C1613F63-DEE3-400A-B960-4BF5A0CC5D45Q63339175-E1869BC2-7FFB-4F31-943F-B7CE1996964CQ63404819-8AA3A122-9620-4396-A6B2-8631ED50917FQ63570980-09D9AC5A-ABC8-42B7-9D7B-DBFDF9DE4A75Q63571684-F08E344D-A26A-4AEC-AD32-88A4BA4A7B33Q63572374-5D117441-D784-455B-8070-8AA777566670Q63572627-EF5D17F8-4DA4-4AE2-9004-0729DD83A93EQ63579518-B7A28A37-8409-4D07-B3B2-280F69040BF6Q63580184-4BB321DC-E086-4016-B1C5-00C7F7A7642CQ86170237-5574BF28-F3D9-4269-9C8F-DE7B39FF5964Q86247729-FC8AB508-E77B-4724-AB70-51FC72779E5FQ87931733-E86A9570-0E2D-4825-BEBE-A6F3980024DB
P4844
Q33397069-47548A21-D1D2-4C38-BF18-6C6D1E17931DQ34090290-E3D72D38-44C9-4BA6-BA77-223F866A3601Q34245815-5AECA3D2-06E2-4B8E-BA2B-C492BB613B1CQ35666418-F666AA10-95FD-4FF6-B160-74A0EC90C6C1Q35666549-DFB2D64E-9B52-4B13-B67A-6834AA3C2E55Q37899198-5049034F-B56E-4CAF-A02F-3159821AE437Q40325816-853F10B5-6DC6-4ACE-859D-F386EB0D97B4Q41103073-8B184827-DBF7-4C35-8D97-7F66CB7447EBQ42559087-4160E7F3-BAB6-4E4E-B421-A2023470915BQ43722780-42A0561B-F823-430B-90E0-26CD6FC1B116Q44769624-3FA89620-B7FE-41D0-8874-D9FF82F6C5BFQ61805112-0A75C71C-F84D-418F-A08F-F2ADA9C08C37Q61806717-95C47EBA-23B2-48CB-BE9C-2C7FA4A83833Q64028001-760418FF-210B-4890-8E9A-7765A1E04E5AQ64065160-D5E382A5-1249-45BF-B701-9A4B61621756Q64104062-00AB0D43-C1EA-4A4B-9AF3-9199613A8E77Q64245296-D3FDBF88-7889-4D0D-BAAE-4CCD8639F477Q64245704-E6B88D42-A255-4C90-BD13-C36EB0D20A9BQ64291148-0D413401-C545-405D-8F55-E75C29CE0B95Q82768948-1A47ADED-9CE4-4C9E-B282-9BE7B3215251
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Linetsolidi
@fi
Linezolid
@de
Linezolid
@es
Linezolid
@gl
Linezolid
@hu
Linezolid
@it
Linezolid
@nl
Linezolid
@ro
Linezolid
@sh
Linezolid
@sl
type
label
Linetsolidi
@fi
Linezolid
@de
Linezolid
@es
Linezolid
@gl
Linezolid
@hu
Linezolid
@it
Linezolid
@nl
Linezolid
@ro
Linezolid
@sh
Linezolid
@sl
altLabel
165800-03-3
@fr
C16H20F1N3O4
@it
C16H20FN3O4
@fr
C16H20FN3O4
@ja
Linezolid
@ar
Linezolid
@cy
Linezolid
@en
Linezolide
@cy
Linezolide
@en
Linezolide
@fr
prefLabel
Linetsolidi
@fi
Linezolid
@de
Linezolid
@es
Linezolid
@gl
Linezolid
@hu
Linezolid
@it
Linezolid
@nl
Linezolid
@ro
Linezolid
@sh
Linezolid
@sl